Ligand Pharmaceuticals Statistics
Total Valuation
GBDC has a market cap or net worth of $3.92 billion. The enterprise value is $8.61 billion.
Important Dates
The next confirmed earnings date is Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
GBDC has 266.39 million shares outstanding. The number of shares has increased by 46.44% in one year.
| Current Share Class | 266.39M |
| Shares Outstanding | 266.39M |
| Shares Change (YoY) | +46.44% |
| Shares Change (QoQ) | +0.81% |
| Owned by Insiders (%) | 1.54% |
| Owned by Institutions (%) | 43.51% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 12.43 and the forward PE ratio is 9.99.
| PE Ratio | 12.43 |
| Forward PE | 9.99 |
| PS Ratio | 4.41 |
| Forward PS | 4.57 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 29.22 |
| EV / Sales | 10.37 |
| EV / EBITDA | n/a |
| EV / EBIT | 12.60 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.26, with a Debt / Equity ratio of 1.19.
| Current Ratio | 3.26 |
| Quick Ratio | 1.84 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 2.64 |
Financial Efficiency
Return on equity (ROE) is 8.88% and return on invested capital (ROIC) is 5.81%.
| Return on Equity (ROE) | 8.88% |
| Return on Assets (ROA) | 5.74% |
| Return on Invested Capital (ROIC) | 5.81% |
| Return on Capital Employed (ROCE) | 7.72% |
| Revenue Per Employee | $948,879 |
| Profits Per Employee | $336,856 |
| Employee Count | 875 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -350,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.66% in the last 52 weeks. The beta is 0.53, so GBDC's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -3.66% |
| 50-Day Moving Average | 14.97 |
| 200-Day Moving Average | 15.06 |
| Relative Strength Index (RSI) | 40.87 |
| Average Volume (20 Days) | 1,120,892 |
Short Selling Information
The latest short interest is 5.62 million, so 2.11% of the outstanding shares have been sold short.
| Short Interest | 5.62M |
| Short Previous Month | 5.94M |
| Short % of Shares Out | 2.11% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.65 |
Income Statement
In the last 12 months, GBDC had revenue of $830.27 million and earned $294.75 million in profits. Earnings per share was $1.18.
| Revenue | 830.27M |
| Gross Profit | 830.27M |
| Operating Income | 683.54M |
| Pretax Income | 282.60M |
| Net Income | 294.75M |
| EBITDA | n/a |
| EBIT | 683.54M |
| Earnings Per Share (EPS) | $1.18 |
Full Income StatementBalance Sheet
The company has $116.93 million in cash and $4.81 billion in debt, giving a net cash position of -$4.69 billion or -$17.61 per share.
| Cash & Cash Equivalents | 116.93M |
| Total Debt | 4.81B |
| Net Cash | -4.69B |
| Net Cash Per Share | -$17.61 |
| Equity (Book Value) | 4.04B |
| Book Value Per Share | 15.04 |
| Working Capital | 224.31M |
Full Balance SheetCash Flow
| Operating Cash Flow | -148.40M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 82.33% and 35.50%.
| Gross Margin | 100.00% |
| Operating Margin | 82.33% |
| Pretax Margin | 35.46% |
| Profit Margin | 35.50% |
| EBITDA Margin | n/a |
| EBIT Margin | 82.33% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.75, which amounts to a dividend yield of 11.70%.
| Dividend Per Share | $1.75 |
| Dividend Yield | 11.70% |
| Dividend Growth (YoY) | -3.31% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 147.77% |
| Buyback Yield | -46.44% |
| Shareholder Yield | -34.74% |
| Earnings Yield | 7.52% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for GBDC is $15.50, which is 5.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.50 |
| Price Target Difference | 5.30% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GBDC has an Altman Z-Score of 0.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.81 |
| Piotroski F-Score | 2 |
